
About JMS
JMS is a publicly listed company based in Hiroshima (Japan) founded in 1965. Dietary supplements for gut health are manufactured and distributed. The company has 5,470 employees. Its chief executive, as recorded, is Hiroaki Okukubo. Its website jms.cc draws about 51 thousand monthly visits. JMS offers products and services including Medical Devices and Sustainability Services. Its focus areas include Traditional Medical Devices. Its legal entity is JMS Co., Ltd.
Company details
Founded in 1965 in Hiroshima, Japan, dietary supplements centered on gut health are produced and distributed by the company. Operations encompass the creation of products such as digestive enzymes, probiotics, and botanical nutrients aimed at supporting digestive function and related wellness aspects. Educational materials on gut health are also shared through online blogs and channels. The focus remains on addressing digestion-specific concerns within the health sector.
- Annual Revenue$412.8 M (USD)-5.6as on Mar 31, 2026
- Net Profit-$4.92 M (USD)-980.9as on Mar 31, 2026
- EBITDA$26.46 M (USD)-11.47as on Mar 31, 2026
- Employee Count5,470
Products & Services of JMS
JMS offers a comprehensive portfolio of products and services, including Medical Devices and Sustainability Services.
Medical devices are produced for applications in healthcare, including support for dialysis and regenerative medicine, to address patient needs.
Sustainability services are offered to manage environmental and social responsibilities, focusing on initiatives that align with corporate goals.
People of JMS
1 people are tracked at JMS (1 in leadership); the tracked headcount is 5,470.
| Name | Role | Group |
|---|---|---|
Hiroaki Okukubo | President & CEO | Leadership |
Complete people profiles for JMS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of JMS
JMS is a publicly listed company on the TSE with ticker symbol 7702 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Mar 1989
- Listed onTSE: 7702
- Listed entityJMS Co., Ltd.
- Exchange sectorHealth technology
- ISINJP3386050003
- Share price442.00 JPY (-0.67% on the day) · 2026-10-14
- Market capitalisation10,872,259,169.00 JPY
- Price to earnings68.0
- EPS (diluted, trailing year)-28.66 JPY
- Dividend yield3.82%
- Volume (last session)26,500
Financials of JMS
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 65.84B JPY | -784.0M JPY | 4.22B JPY |
| 2024 | 69.75B JPY | 89.0M JPY | 4.76B JPY |
| 2023 | 65.29B JPY | -36.0M JPY | 3.45B JPY |
| 2022 | 63.74B JPY | 280.0M JPY | 4.32B JPY |
| 2021 | 58.17B JPY | 825.0M JPY | 4.34B JPY |
Detailed financial statements for JMS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of JMS
The website of JMS (jms.cc) receives about 51.3K visits a month.
- Monthly visits51.3K
▲ 4.1% vs previous month
Websites whose visitors overlap most with JMS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
hope-denshi.co.jp | hope-denshi.co.jp | 100% | #8,531,116 | β | |
cardinalhealth-info.jp | cardinalhealth-info.jp | 84% | #687,910 | β | |
gadeliusmedical.com | gadeliusmedical.com | 82% | #2,967,522 | β | |
bbraun.jp | bbraun.jp | 81% | #1,170,910 | β | |
www3.gehealthcare.co.jp | www3.gehealthcare.co.jp | 80% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for JMS
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jms
Complete news archive for JMS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JMS
JMS was founded in 1965.
JMS is headquartered in Hiroshima, Japan.
Hiroaki Okukubo is the CEO of JMS, as recorded in our data.
JMS has 5,470 employees.
Annual revenue of JMS is $412.8M as on Mar 31, 2026.
Founded in 1965 in Hiroshima, Japan, dietary supplements centered on gut health are produced and distributed by the company. Operations encompass the creation of products such as digestive enzymes, probiotics, and botanical nutrients aimed at supporting digestive function and related wellness aspects. Educational materials on gut health are also shared through online blogs and channels. The focus remains on addressing digestion-specific concerns within the health sector.
JMS offers Medical Devices and Sustainability Services.
Yes, JMS is publicly traded on TSE under the ticker symbol 7702.
JMS operates through Jms Co., Ltd..
